News
Your contact
Gabriele Klingner
Communications & Marketing Lead
Christiane Proll
PR & Social Media Manager
News and articles from BioM about and for the Bavarian biotechnology industry.
-
Bavaria x Australia: Exploring New Models of Global Clinical Trial Collaboration10.03.2026Bavaria x Australia: Exploring New Models of Global Clinical Trial CollaborationClinical trials become more complex and collaborative! This session explores how Australia’s clinical trial ecosystem is structured, its key strengths and efficiencies, and opportunities for… -
BIO-Europe Spring 2026: Bio<sup>M</sup> will attend to represent the Bavarian Biotech Cluster10.03.2026BIO-Europe Spring 2026: BioM will attend to represent the Bavarian Biotech ClusterThis March, BIO-Europe Spring returns for a dynamic in-person experience, and BioM is excited to invite you to join us! From March 23-25 2026, BIO-Europe Spring will take place in Lisbon… -
Technology for strong muscles: Noxon secures millions in financing for market entry02.03.2026Technology for strong muscles: Noxon secures millions in financing for market entryMunich-based medical technology startup Noxon has completed a seed financing round worth millions. The round is led by High-Tech Gründerfonds (HTGF), with Bayern Kapital, Auxxo, and another… -
Delegation Trip of European Life Sciences Companies to China02.03.2026Delegation Trip of European Life Sciences Companies to ChinaAre you interested in the Chinese life sciences market? Then join the delegation trip to China organized by CIPA (China International Investment Promotion Agency (Germany)) and discover… -
Ethris receives EU funding of up to EUR 148 million for novel pandemic influenza vaccines through consortium26.02.2026Ethris receives EU funding of up to EUR 148 million for novel pandemic influenza vaccines through consortiumEthris, based in Planegg/Munich, Germany, together with the European consortium NOFLU, has received initial funding of EUR 13 million to advance an innovative mRNA-based mucosal vaccine… -
Expanded MoU signed between Bavaria and Japan: Bio<sup>M</sup>, City of Kawasaki, and KIIP intensify cooperation in the life sciences25.02.2026Expanded MoU signed between Bavaria and Japan: BioM, City of Kawasaki, and KIIP intensify cooperation in the life sciencesThe Bavarian biotech cluster organization BioM Biotech Cluster Development GmbH (BioM), the City of Kawasaki, Japan, and the Kawasaki Institute of Industrial Promotion (KIIP) re-signed an… -
Financial Times Ranking 2026: Bavaria Leads Europe’s Startup Hubs – Momentum for Life Sciences25.02.2026Financial Times Ranking 2026: Bavaria Leads Europe’s Startup Hubs – Momentum for Life SciencesThe Financial Times has published its third ranking of Europe’s leading startup hubs. In the 2026 edition, 180 innovation and entrepreneurship centers from 25 countries were evaluated based… -
Swiss Biotech Day 2026: Join the Bavarian Booth!23.02.2026Swiss Biotech Day 2026: Join the Bavarian Booth!The Swiss Biotech Day will again take place from May 4th to 5th 2026 in Basel (Switzerland). The SBD has become a premier global biotechnology conference for life sciences, offering a unique… -
RNATICS secures 2.7 million Euros BMFTR grant RCS-21 advances in clinical development20.02.2026RNATICS secures 2.7 million Euros BMFTR grant RCS-21 advances in clinical developmentMunich start-up RNATICS GmbH has been awarded 2.7 million Euros in funding from the Federal Ministry of Research, Technology and Space (BMFTR). The grant supports the next stage of clinical… -
Roche celebrates official inauguration of new diagnostics innovation center “LEAP” in Penzberg12.02.2026Roche celebrates official inauguration of new diagnostics innovation center “LEAP” in PenzbergAfter around four years of construction, a new diagnostics innovation center has been completed in Penzberg – a modern, sustainable facility in which Roche has invested approximately 300…